Global Trac Solutions, Inc. CEO, David Flores, sits down once again with Founder & CEO of The Third Wave, Paul F. Austin. The two begin their conversation with accessibility & affordability, concepts that are commonly overlooked in psychedelic medicine. They then dive into what it would take to create an infrastructure that ensures a very important segment of our society is able to gain access to the powerful, and profound benefits available through the use of psychedelic medicine.
Similar Posts
Compass Pathways Study Finds SSRI Drugs Did Not Impede Psilocybin’s Therapeutic Effect
Chief Medical Officer Guy Goodwin calls study “a strong signal that COMP360 psilocybin therapy could be an adjunctive treatment to SSRI antidepressant as well as a monotherapy.”
GH Research Raises $125 Million to Fund DMT Treatment for Depression
GH Research closed a $125 million Series B financing round to fund the advancement of its 5-MeO-DMT treatment.
30 Under 30 Women In Psychedelics
Psychedelic careers have boomed in the past few years. Paving…
Is the Trip Enough? Why Psychedelic Integration Therapy Is Important to Maximize the Benefits of Your Trip
Psychedelic integration therapy is a powerful, essential tool that can maximize the therapeutic benefits of psychedelic experiences.
Compass Pathways Phase 2 Psilocybin Results far from Spectacular
Psilocybin showed rapid antidepressant effects for most patients, but only 1 in 5 participants showed significant improvement at 12 weeks
Psychedelic Business News Spotlight: May 7, 2021
This week in psychedelic business news: LSD for pain, DMT and organ transplants, Champignon Brands is now Braxia Scientific Corp, and more.